$AKAN Income Statement | Understand Stock

$AKAN

$1.05 +$0.04 (3.96%) Close

$AKAN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Loss and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Sales
Cost of sales
Gross Profit before gain (loss) on change in fair value of biological assets and inventory
Gain (Loss) on change in fair value of biological assets and inventory
Gross Profit (Loss)
Operating expenses
Depreciation and amortization
Consulting and professional fees
Personnel expenses
Travel expenses
Share-based payment expenses to social development trust
License fees
Total operating expenses

Operating loss
Other income (expenses):
Finance income
Finance expense
Foreign exchange loss, net
Foreign exchange gain (loss), net
Gain on bargain purchase
Transaction costs
Change in fair value of financial liabilities measured at FVTPL
Total other (expense) income:
Loss on disposal of assets
Other income
Gain on sale of subsidiary
Write-off of AP, net
Write-off of holdback payable
Write-off of loan receivable
Impairment loss
Total Other income

Net loss from continuing operations
Gain (loss) from discontinued operation
Net loss
Net comprehensive loss attributable to:
Shareholders of the Company
Non-controlling interest
Translation adjustment
Comprehensive loss
Loss per share from continuing operations – basic (in Dollars per share)
Loss per share from continuing operations – diluted (in Dollars per share)
Loss per share – basic (in Dollars per share)
Loss per share – diluted (in Dollars per share)
Weighted average common shares outstanding (in Shares)
Weighted average common shares outstanding - diluted
Net loss attributable to:
Shareholders of the Company
Non-controlling interest

Comments